MBRX (Moleculin Biotech) Institutional Ownership: 3.14% (As of Jul. 11, 2026)


MBRX Moleculin Biotech Inc MBRX
30 GF Score
Price $2.28
! 1 Warning Sign
View Full Analysis

What is Moleculin Biotech Institutional Ownership?

Moleculin Biotech MBRX -6.94% 30 Institutional Ownership is 3.14% as of Jul. 11, 2026. GuruFocus rates MBRX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Moleculin Biotech's institutional ownership is 3.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Moleculin Biotech's Insider Ownership is 1.12%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Moleculin Biotech's Float Percentage Of Total Shares Outstanding is 99.28%.

Moleculin Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Moleculin Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moleculin Biotech Institutional Ownership Chart

Moleculin Biotech Historical Data

The historical data trend for Moleculin Biotech can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 1.26 1.46 1.41 1.45 1.45 0.84 1.25 1.39 0.83 0.63
MBRX
30GF Score
Moleculin Biotech Inc MBRX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moleculin Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.14% mean?
Moleculin Biotech (MBRX) has a Institutional Ownership of 3.14% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Moleculin Biotech and its competitors.
Is Moleculin Biotech's Institutional Ownership too high?
Moleculin Biotech's current Institutional Ownership is 3.14%. Overall, Moleculin Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Moleculin Biotech's Institutional Ownership compare to JAGX and BCDA?
Moleculin Biotech's Institutional Ownership of 3.14% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Moleculin Biotech and its competitors. Moleculin Biotech's current Institutional Ownership is 3.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moleculin Biotech stock overvalued right now?
Moleculin Biotech (MBRX) has a current Institutional Ownership of 3.14%. The current Institutional Ownership is 3.14%. Moleculin Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Moleculin Biotech (MBRX), the current Institutional Ownership is 3.14% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Moleculin Biotech Business Description

Other Exchanges 0K2H:UK
Address 5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
30GF Score

Get the complete analysis for MBRX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.28
Price